The potential for α-klotho to serve as a biomarker of kidney function has been suggested in recent decades on the basis of reduced renal production of α-klotho in patients with CKD [16–18]; moreover, reduced levels of sKL are reportedly associated with the prevalence of anemia in patients with CKD [19]. Here, KL is linked to chronic kidney disease.